Literature DB >> 25082006

Quantitative proteomic analysis of the cell envelopes and native membrane vesicles derived from gram-negative bacteria.

Ryszard A Zielke1, Philip R Gafken, Aleksandra E Sikora.   

Abstract

Proteins localized to the cell envelope and naturally released membrane vesicles (MVs) play diverse functions in physiology and pathogenesis of Gram-negative bacteria. Study of these proteome fractions is essential for better understanding the basic physiological processes, development of vaccines, and identification of potential drug targets. This unit presents gel-free quantitative proteomic methods for comprehensive proteomic profiling of the cell envelopes and MVs. The procedure starts with the precipitation of the isolated proteome fractions to remove any potential compounds that may interfere with downstream experimental steps. Subsequently, the proteins are reduced, alkylated, and subjected to trypsin digestion. The trypsinized peptides are labeled using isobaric tagging for relative and absolute quantification (iTRAQ), and analyzed samples are pooled and subjected to rigorous prefractionations by strong cation exchange (SCX) and reversed-phase (RP) liquid chromatography (LC). Finally, the tandem mass spectrometry (MS/MS) fragmentation enables peptides identification and quantification.
Copyright © 2014 John Wiley & Sons, Inc.

Entities:  

Keywords:  2D-LC-MS/MS; bioinformatics; cell envelope; iTRAQ; native membrane vesicles; quantitative proteomics

Mesh:

Substances:

Year:  2014        PMID: 25082006     DOI: 10.1002/9780471729259.mc01f03s34

Source DB:  PubMed          Journal:  Curr Protoc Microbiol


  6 in total

1.  A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection.

Authors:  Aleksandra E Sikora; Carolina Gomez; Adriana Le Van; Benjamin I Baarda; Stephen Darnell; Fabian G Martinez; Ryszard A Zielke; Josephine A Bonventre; Ann E Jerse
Journal:  Vaccine       Date:  2020-11-05       Impact factor: 3.641

2.  Peptide Inhibitors Targeting the Neisseria gonorrhoeae Pivotal Anaerobic Respiration Factor AniA.

Authors:  Aleksandra E Sikora; Robert H Mills; Jacob V Weber; Adel Hamza; Bryan W Passow; Andrew Romaine; Zachary A Williamson; Robert W Reed; Ryszard A Zielke; Konstantin V Korotkov
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

3.  Quantitative Proteomics of the 2016 WHO Neisseria gonorrhoeae Reference Strains Surveys Vaccine Candidates and Antimicrobial Resistance Determinants.

Authors:  Fadi E El-Rami; Ryszard A Zielke; Teodora Wi; Aleksandra E Sikora; Magnus Unemo
Journal:  Mol Cell Proteomics       Date:  2018-10-23       Impact factor: 5.911

4.  Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.

Authors:  Ryszard A Zielke; Igor H Wierzbicki; Benjamin I Baarda; Philip R Gafken; Olusegun O Soge; King K Holmes; Ann E Jerse; Magnus Unemo; Aleksandra E Sikora
Journal:  Mol Cell Proteomics       Date:  2016-05-02       Impact factor: 5.911

5.  Detection of bacterial-reactive natural IgM antibodies in desert bighorn sheep populations.

Authors:  Brian S Dugovich; Melanie J Peel; Amy L Palmer; Ryszard A Zielke; Aleksandra E Sikora; Brianna R Beechler; Anna E Jolles; Clinton W Epps; Brian P Dolan
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

Review 6.  Proteomics, Bioinformatics and Structure-Function Antigen Mining For Gonorrhea Vaccines.

Authors:  Benjamin I Baarda; Fabian G Martinez; Aleksandra E Sikora
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.